XML 29 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Net income $ 62,804 $ 66,211 $ 70,058
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 20,813 19,692 15,022
Amortization of unfavorable contract liability to revenue 0 0 (2,670)
Amortization of deferred revenue (1,085) (596) (307)
Amortization of deferred financing costs 1,460 1,460 1,267
Accretion of asset retirement obligations 266 251 232
(Gain) loss on asset disposals (16) 104 83
Deferred income taxes (173) 14 (109)
Loss on equity method investments 1,178 588 0
Unit-based compensation expense 599 406 274
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable 15,847 (7,197) 2,892
Inventories and other current assets 2,045 (907) 7,894
Accounts payable and other current liabilities 3,551 (13,734) (7,117)
Accounts receivable/payable to related parties (6,983) 1,737 (885)
Non-current assets and liabilities, net 401 (5) (1,550)
Net cash provided by operating activities 100,707 68,024 85,084
Cash flows from investing activities:      
Business combinations 0 (400) (22,650)
Purchases of property, plant and equipment (11,287) (19,956) (9,012)
Proceeds from sales of property, plant and equipment 175 1,198 0
Equity method investments (61,580) (37,434) 0
Net cash used in investing activities (72,692) (56,592) (31,662)
Cash flows from financing activities:      
Proceeds from issuance of additional units to maintain 2% General Partner interest 29 50 45
Distributions to general partner (10,244) (3,918) (1,382)
Distributions to common unitholders - public (23,847) (20,755) (17,099)
Distributions to common unitholders - Delek (25,271) (6,046) (5,053)
Distributions to subordinated unitholders - Delek (11,503) (25,919) (21,658)
Distributions to Delek for acquisitions 0 (61,890) (95,900)
Proceeds from revolving credit facility 314,750 396,400 499,750
Payments of revolving credit facility (273,750) (296,550) (412,800)
Deferred financing costs paid 0 0 (3,688)
Predecessor division equity contribution 0 115 3,722
Reimbursement of capital expenditures by Delek 1,880 5,220 1,578
Net cash used in financing activities (27,956) (13,293) (52,485)
Net increase (decrease) in cash and cash equivalents 59 (1,861) 937
Cash and cash equivalents at the beginning of the period 0 1,861 924
Cash and cash equivalents at the end of the period 59 0 1,861
Cash paid during the period for:      
Interest 12,206 9,009 7,661
Income taxes 224 4 18
Non-cash investing activities:      
Equity method investments 0 3,832 0
Increases in accrued capital expenditures 480 2,471 156
Non-cash financing activities:      
Sponsor contribution of fixed assets $ 5,167 $ 584 $ 1,566